Caffeine supplement, inflammation, and hepatic function in cirrhotic patients: A randomized, placebo- controlled, clinical trial
The results of the present study indicated that daily supplementation of 400 mg caffeine in cirrhotic patients can significantly improve liver fibrosis and reduce inflammatory factors.The trial was registered at the Iranian Registry of Clinical Trials (Registration ID: IRCT20100524004010N34).
Authors
- Amir Anushiravani (ORCID: https://orcid.org/0000-0002-9196-1901)
- Azita Hekmatdoost (ORCID: https://orcid.org/0000-0002-1944-0052)
- Behzad Hatami (ORCID: https://orcid.org/0000-0001-9635-4345)
- Shadi Kolahdoozan (ORCID: https://orcid.org/0000-0002-0149-0879)
- Nadia Akbarzadeh
- Ali Zamanian (ORCID: https://orcid.org/0000-0003-1846-2118)
- Zahra Yari (ORCID: https://orcid.org/0000-0003-2796-2413)
- Seyed Ali Abbas‐Hashemi (ORCID: https://orcid.org/0000-0002-8347-3625)
Institutions
- National Nutrition and Food Technology Research Institute (IR)
- Shahid Beheshti University (IR)
- Shahid Beheshti University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Heliyon
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e41138
- Primary Topic
- Coffee research and impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shahid Beheshti University of Medical Sciences